Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NFIB dependent and independent mechanisms of metastasis in small cell lung cancer [RNA-seq]

ABSTRACT: NFIB dependent and independent mechanisms of metastasis in small cell lung cancer [RNA-seq]

PROVIDER: PRJNA949350 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23984844_1.fastq.gz	Fastqsanger.gz
	SRR23984844_2.fastq.gz	Fastqsanger.gz
	SRR23984845_1.fastq.gz	Fastqsanger.gz
	SRR23984845_2.fastq.gz	Fastqsanger.gz
	SRR23984846_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

NFIB dependent and independent mechanisms of metastasis in small cell lung cancer

Project description:NFIB dependent and independent mechanisms of metastasis in small cell lung cancer

| PRJNA949286 | ENA

NFIB dependent and independent mechanisms of metastasis in small cell lung cancer [ATAC-seq]

Project description:NFIB dependent and independent mechanisms of metastasis in small cell lung cancer [ATAC-seq]

| PRJNA946306 | ENA

NFIB dependent and independent mechanisms of metastasis in small cell lung cancer [ATAC-seq]

Project description:Molecular characterization of lung tumors and liver metastases from SCLC mouse models with and without Nfib knockout. We performed gene expression profiling analysis using data obtained from ATAC-seq of 7 mouse SCLC cell lines.

2023-11-07 | GSE227669 | GEO

NFIB dependent and independent mechanisms of metastasis in small cell lung cancer [RNA-seq]

2023-11-07 | GSE228333 | GEO

NFIB dependent and independent mechanisms of metastasis in small cell lung cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-11-07 | GSE228334 | GEO

Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.

Project description:Metastasis is a major cause of morbidity and mortality in patients with cancer, highlighting the need to identify improved treatment and prevention strategies. Previous observations in preclinical models and tumors from patients with small cell lung cancer (SCLC), a fatal form of lung cancer with high metastatic potential, identified the transcription factor NFIB as a driver of tumor growth and metastasis. However, investigation into the requirement for NFIB activity for tumor growth and metastasis in relevant in vivo models is needed to establish NFIB as a therapeutic target. Here, using conditional gene knockout strategies in genetically engineered mouse models of SCLC, we found that upregulation of NFIB contributes to tumor progression, but NFIB is not required for metastasis. Molecular studies in NFIB wild-type and knockout tumors identified the pioneer transcription factors FOXA1/2 as candidate drivers of metastatic progression. Thus, while NFIB upregulation is a frequent event in SCLC during tumor progression, SCLC tumors can employ NFIB-independent mechanisms for metastasis, further highlighting the plasticity of these tumors.SignificanceSmall cell lung cancer cells overcome deficiency of the prometastatic oncogene NFIB to gain metastatic potential through various molecular mechanisms, which may represent targets to block progression of this fatal cancer type.

| S-EPMC10842891 | biostudies-literature

RNA-Seq of 3 breast cancer models to investigate NFIB signalling role in metastatic colonization.

Project description:Next Generation Sequencing was applied to investigate molecular mechanisms underlying the increased metastatic colonization driven by Nfib. Global transcriptional profiling of primary tumours derived from Nfib high-expression models (LM1 and LM9) and Nfib low-expression models (HR1) allowed to identify Ero1l as a mediator of metastasis upon Nfib upregulation.

2021-01-15 | GSE144392 | GEO

RNA-Seq of 2 lung metastatic breast cancer cell lines and their Nfib Kos.

Project description:Next Generation Sequencing was applied to investigate molecular mechanisms underlying the increased metastatic colonization driven by Nfib. Global transcriptional profiling of the lung metastatic cell lines and respective KOs allowed to identify Ero1l as a mediator of metastasis upon Nfib upregulation.

2021-01-15 | GSE144393 | GEO

The NFIB/CARM1 Partnership is a Therapeutic Target for Small Cell Lung Cancer

Project description:This project identified NFI family members as CARM1 substrates. NFIB was previously reported to play a critical role in the development of small cell lung cancer. We provided evidence that the arginine methylation of NFIB is required for its oncogenic function in small cell lung cancer.

2023-02-07 | PXD038237 | Pride

Nfib promotes Metastasis through a Widespread Increase in Chromatin Accessibility

Project description:Nfib promotes Metastasis through a Widespread Increase in Chromatin Accessibility

| PRJNA321069 | ENA